Druggable gene alterations in Japanese patients with rare malignancy

Without a current standard of care, patients with rare malignancy are subjected to precision oncology with next-generation sequencing to identify a course of treatment. We sought to establish the clinical relevance of comprehensive genomic profiling (CGP) among patients with rare malignancy. Rare ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohmoto, Akihiro, Hayashi, Naomi, Fukada, Ippei, Yamazaki, Masumi, Yunokawa, Mayu, Kasuga, Akiyoshi, Shinozaki, Eiji, Ueki, Arisa, Tonooka, Akiko, Takeuchi, Kengo, Mori, Seiichi, Kiyotani, Kazuma, Takahashi, Shunji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471185/
https://www.ncbi.nlm.nih.gov/pubmed/36088851
http://dx.doi.org/10.1016/j.neo.2022.100834

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471185/
https://www.ncbi.nlm.nih.gov/pubmed/36088851
http://dx.doi.org/10.1016/j.neo.2022.100834

Ejemplares similares